Cytisinicline Nears FDA Nod as First New Smoking Cessation Drug
With PDUFA date set for June 20, 2026, cytisinicline could become the first novel smoking cessation pharmacotherapy approved by FDA in nearly 20 years.
April 14, 20265 min read
Blog & News
Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
Alltreatment-accessTreatment AccessOpioid CrisisFederal PolicyHarm Reductionopioid-crisisClinical Researchfederal-policysubstance-use-disorderSubstance Use Disordermedication-assisted-treatmentopioid-addictionMedication-Assisted Treatmentclinical-researchOpioid AddictionState Legislationstate-legislationdata-reportsMental Healthharm-reductionFundingmental-healthPsychedelicsfundingClinical TrialsData Reportsclinical-trialsbehavioral-therapypsychedelicsAlcohol Addictionbuprenorphinetelehealthdigital-healthBuprenorphineStimulant Addictionalcohol-addictionTelehealthMedication Assisted TreatmentBehavioral Therapyrural-healthcareSubstance-Use-DisorderDigital HealthSynthetic Opioidsstimulant-addictionmarijuana-dependencepeer-recoveryyouthmobile-healthFederal-PolicyClinical-TrialsClinical-ResearchLitigationInternationalTreatment OptionsRecoveryRehabilitationResearch
FDA MDMA Rejection Triggers Psychedelic Industry Reset
Lykos Therapeutics slashes workforce by 75% after Complete Response Letter reveals FDA concerns about trial design and durability, forcing psychedelic research firms to reconsider regulatory strategy.
April 14, 20267 min read
Iowa Opens $10M Opioid Crisis Round From Settlement Funds
Iowa launches competitive grant program directing 75% of opioid settlement funds toward prevention, treatment, and recovery services across the state.
April 14, 20264 min read
Mirtazapine Cuts Meth Use in Australian Phase 3 Tina Trial
Phase 3 study of 339 adults finds cheap, widely available medication cuts meth use by seven days per month, offering first pharmacological treatment option for stimulant use disorder.
April 13, 20267 min read
Wisconsin Allocates $31M in Opioid Settlement to Tribes, Care
State health officials announce two-year spending plan prioritizing disproportionately impacted populations, room and board assistance for residential treatment, and naloxone distribution as overdose deaths decline 42.5%.
April 10, 202610 min read
CDC Warns 'Rhino Tranq' Fentanyl Resists Naloxone
Federal health officials alert providers to medetomidine, a potent animal sedative spreading through the illegal opioid supply, causing naloxone-resistant overdoses and life-threatening withdrawal.
April 9, 20268 min read
NIH Engineers DFNZ: Pain Relief Without Addiction Risk
National Institute on Drug Abuse researchers transform a dangerous synthetic opioid class into a potential therapeutic, creating a compound that relieves pain without causing tolerance, dependence, or fatal overdose risk.
April 9, 20268 min read
Rainier Rehab
Understanding Your Addiction Treatment Options: A Comprehensive Guide
Explore the various addiction treatment options available, from detox and inpatient rehab to outpatient programs and aftercare support.
April 8, 20263 min read
ASAM Issues First Addiction Treatment Standards for Youth
New clinical criteria establish age-specific guidelines for patients under 18 and transition-aged youth 16-25, emphasizing family involvement and developmentally appropriate care.
April 7, 20264 min read